Join our upcoming webinar to explore the innovative world of RNA liquid biopsies. Learn how the advanced COMPLETE-seq technology utilizes nanopore sequencing to detect full-length, cell-free RNAs from cancer patients, revealing thousands of novel RNA sequences.
In this webinar you’ll learn how:
In this webinar you’ll learn how:
- RNA liquid biopsy technology enables highly sensitive and specific cancer detection in a minimally invasive way
- Repetitive cell-free RNAs are enriched in cancer patients and can be leveraged to improve disease classification
- Nanopore sequencing reveals full-length cell-free RNAs, including thousands of novel and disease-specific RNAs
- Cancer researchers
- Genomics researchers
- Diagnostics researchers
- RNA researchers